CMS to provide Medicare Part D beneficiaries with $50 monthly access to certain GLP-1 medications
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible Medicare Part D beneficiaries for $50 per month beginning July 1 this year through Dec. 31, 2027. The program will be conducted under the agency’s short-term demonstration, the Medicare GLP-1 Bridge. The demonstration is tied to CMS’ Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth Model, or BALANCE, which is designed to increase access to GLP-1 medications and other healthy lifestyle interventions.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029. The…
Headline
The estimated average monthly premium for Medicare Part D stand-alone prescription drug plans is $51 for 2027, a 50% increase from $34 in 2026, for enrollees…
Headline
The Centers for Medicare & Medicaid Services released a proposed rule Oct. 16 seeking to codify regulations that will improve the accuracy of Medicare…
Headline
The Centers for Medicare & Medicaid Services announced that it will exercise enforcement discretion for inpatient rehabilitation facility admissions from…
Headline
The Centers for Medicare & Medicaid Services has released 2027 Medicare Advantage plan information, including star ratings, through the Medicare Plan…
Headline
The AHA provided comments to the Medicare Payment Advisory Commission Oct. 2 on a discussion from the commission’s September meeting on its examination of…